3 hours The Goldman Sachs Group Trims Maravai LifeSciences (NASDAQ:MRVI) Target Price to $7.00 MarketBeat
The Goldman Sachs Group lowered their price target on shares of Maravai LifeSciences from $8.00 to $7.00 and set a “neutral” rating for the company in a report on Tuesday.
Goldman Sachs (GS) · Nasdaq 100